India is likely to get the first lot of anti-Covid shots in late
January-early February. This will be possible as India plans to give
Serum Institute of India emergency use approval for the
Oxford-AstraZeneca vaccine candidate soon after it gets similar
approval in the UK. The government, which will make bulk purchases,
has also negotiated a better price — almost half that of the likely
MRP of Rs 500-600 for the two-shot vaccine.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/covid-19-govt-may-get-oxford-shots-in-jan-feb-at-50-of-mrp/articleshow/79361456.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment